26 January, 2024
We warmly welcomed a 6-member Bhutan Food and Drug Authority team as they visited our ABHL plant for the GMP certificate renewal audit from January 24-26, 2024. We are excited to announce the audit's success, reaffirming our commitment to excellence. To mark this milestone, we captured memorable moments with the BFDA team during their visit and are grateful to the BFDA team for their meticulous evaluation and collaboration. We are delighted that collaboratively, we are paving the way for excellence in the pharmaceutical industry!
24 February, 2024
Transforming Bhutan’s Healthcare Azista Bhutan Healthcare Limited Leads the Charge Thimphu, Bhutan24 February, 2024
Team Blood Donation Drive28 December, 2024
A Plant Visit Recap - ABHL Hosts DHI Group's Menjong Sorig31st October 2023
ABHL(Azista Bhutan Healthcare Limited) participated in a Prestigious Consultation Event We are proud to announce that ABHL(Azista Bhutan Healthcare Limited) recently participated in a significant consultation event. This event was jointly organized by the United Nations Development Programme (UNDP) and the Bhutan Food and Drug Authority (BFDA). Furthermore, it was generously sponsored by the Access Delivery Partnership (ADP). The collaboration between such esteemed organizations underscores the importance of the event and its objectives. As a leading healthcare provider in Bhutan, our participation signifies our commitment to aligning with global standards and best practices. We are grateful for the opportunity to collaborate, share insights, and learn from other industry leaders.
To order or to know more details about Menthopas, reach us by filling the form. We will get back you within 1-2 business days.